國立虎尾科技大學 |

Pharmacological Treatment of Chronic Stable Angina Pectoris

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Pharmacological Treatment of Chronic Stable Angina Pectoris/ edited by Pablo Avanzas, Juan Carlos Kaski.
其他作者:	Avanzas, Pablo.
面頁冊數:	XI, 278 p. 32 illus., 23 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Cardiology. -
電子資源:	https://doi.org/10.1007/978-3-319-17332-0
ISBN:	9783319173320

Pharmacological Treatment of Chronic Stable Angina Pectoris
Pharmacological Treatment of Chronic Stable Angina Pectoris[electronic resource] /edited by Pablo Avanzas, Juan Carlos Kaski. - 1st ed. 2015. - XI, 278 p. 32 illus., 23 illus. in color.online resource. - Current Cardiovascular Therapy. - Current Cardiovascular Therapy.

Mechanisms of angina -- An overview of treatment and guidelines – ESC /ACC-AHA/ NICE -- Beta-blockers -- Calcium channel blockers -- Nitrates -- Nicorandil -- Ivabradine. Trimetazidine -- Ranolazine -- New antianginal drugs still not available for clinical use -- Medical therapy versus revascularization in the management of stable angina pectoris.

This book describes the clinical challenge currently posed by stable angina pectoris and provides guidance for those making clinical decisions regarding its pharmacological treatment. The importance of providing effective treatment is beyond dispute and this book deals with the most relevant aspects related to its pharmacological treatment. The pathogenesis of myocardial ischemia as the basis for rational treatment of angina is discussed thoroughly together with all major management goals including optimal symptom control and the secondary prevention of serious cardiovascular events. Pharmacological Treatment of Chronic Stable Angina Pectoris provides a clear description of the mechanisms of action and clinical indications of available anti-angina drugs and strategies for the use of novel pharmacological agents. It also includes a critical appraisal of the major management guidelines, which will assist the reader to interpret current evidence and provide the most appropriate forms of treatment. The ongoing controversy regarding medical therapy versus myocardial revascularization for the management of stable angina pectoris is also addressed. This eminently practical book will help guiding the reader through the complexities of the field and will be highly appreciated by clinicians, clinical cardiologists and cardiology trainees alike.

ISBN: 9783319173320

Standard No.: 10.1007/978-3-319-17332-0doiSubjects--Topical Terms:

593957
Cardiology.

LC Class. No.: RC681-688.2

Dewey Class. No.: 616.12

Pharmacological Treatment of Chronic Stable Angina Pectoris
LDR:03063nam a22003975i 4500 001 970183
003 DE-He213
005 20200706053300.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319173320 $9 978-3-319-17332-0
024 7 $a 10.1007/978-3-319-17332-0 $2 doi
035 $a 978-3-319-17332-0
050 4 $a RC681-688.2
072 7 $a MJD $2 bicssc
072 7 $a MED010000 $2 bisacsh
072 7 $a MJD $2 thema
082 0 4 $a 616.12 $2 23
245 1 0 $a Pharmacological Treatment of Chronic Stable Angina Pectoris $h [electronic resource] / $c edited by Pablo Avanzas, Juan Carlos Kaski.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a XI, 278 p. 32 illus., 23 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Current Cardiovascular Therapy
505 0 $a Mechanisms of angina -- An overview of treatment and guidelines – ESC /ACC-AHA/ NICE -- Beta-blockers -- Calcium channel blockers -- Nitrates -- Nicorandil -- Ivabradine. Trimetazidine -- Ranolazine -- New antianginal drugs still not available for clinical use -- Medical therapy versus revascularization in the management of stable angina pectoris.
520 $a This book describes the clinical challenge currently posed by stable angina pectoris and provides guidance for those making clinical decisions regarding its pharmacological treatment. The importance of providing effective treatment is beyond dispute and this book deals with the most relevant aspects related to its pharmacological treatment. The pathogenesis of myocardial ischemia as the basis for rational treatment of angina is discussed thoroughly together with all major management goals including optimal symptom control and the secondary prevention of serious cardiovascular events. Pharmacological Treatment of Chronic Stable Angina Pectoris provides a clear description of the mechanisms of action and clinical indications of available anti-angina drugs and strategies for the use of novel pharmacological agents. It also includes a critical appraisal of the major management guidelines, which will assist the reader to interpret current evidence and provide the most appropriate forms of treatment. The ongoing controversy regarding medical therapy versus myocardial revascularization for the management of stable angina pectoris is also addressed. This eminently practical book will help guiding the reader through the complexities of the field and will be highly appreciated by clinicians, clinical cardiologists and cardiology trainees alike.
650 0 $a Cardiology. $3 593957
700 1 $a Avanzas, Pablo. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1021441
700 1 $a Kaski, Juan Carlos. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 884292
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319173313
776 0 8 $i Printed edition: $z 9783319173337
830 0 $a Current Cardiovascular Therapy $3 1021443
856 4 0 $u https://doi.org/10.1007/978-3-319-17332-0
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)